| abstract |
The invention relates to the pharmaceutical composition of the active compound, 3-Z- [1- (4- (N - ((4-methylpiperazin-1-yl) methylcarbonyl) -N-methylamino) anilino) -1-phenylmethylene] -6-methoxycarbonyl monoethane sulfonate -2-indolinone comprising a lipid suspension of the indicated active compound in 1-90 wt.% Triglycerides with an average chain length, 1-30 wt.% Solid fat and 0.1-10 wt.% Lecithin. The present invention also relates to a capsule, which comprises a shell and an encapsulated composition comprising a pharmaceutical composition according to the invention. The pharmaceutical composition according to the invention provides treatment of oncological diseases, immunological diseases or pathological conditions, including an immunological component, and fibrotic diseases. |